BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 29760712)

  • 21. MicroRNA expression during osteogenic differentiation of human multipotent mesenchymal stromal cells from bone marrow.
    Gao J; Yang T; Han J; Yan K; Qiu X; Zhou Y; Fan Q; Ma B
    J Cell Biochem; 2011 Jul; 112(7):1844-56. PubMed ID: 21416501
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A 9 series microRNA signature differentiates between germinal centre and activated B-cell-like diffuse large B-cell lymphoma cell lines.
    Culpin RE; Proctor SJ; Angus B; Crosier S; Anderson JJ; Mainou-Fowler T
    Int J Oncol; 2010 Aug; 37(2):367-76. PubMed ID: 20596664
    [TBL] [Abstract][Full Text] [Related]  

  • 23. miR-17∼92 in lymphocyte development and lymphomagenesis.
    Labi V; Schoeler K; Melamed D
    Cancer Lett; 2019 Apr; 446():73-80. PubMed ID: 30660648
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNAs: Novel immunotherapeutic targets in colorectal carcinoma.
    Li X; Nie J; Mei Q; Han WD
    World J Gastroenterol; 2016 Jun; 22(23):5317-31. PubMed ID: 27340348
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of microRNAs in B-cell development and function.
    Li J; Wan Y; Ji Q; Fang Y; Wu Y
    Cell Mol Immunol; 2013 Mar; 10(2):107-12. PubMed ID: 23314697
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in E(mu)-miR155 transgenic mice.
    Costinean S; Zanesi N; Pekarsky Y; Tili E; Volinia S; Heerema N; Croce CM
    Proc Natl Acad Sci U S A; 2006 May; 103(18):7024-9. PubMed ID: 16641092
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of microRNAs in autoimmune diseases with skin involvement.
    Deng X; Su Y; Wu H; Wu R; Zhang P; Dai Y; Chan TM; Zhao M; Lu Q
    Scand J Immunol; 2015 Mar; 81(3):153-65. PubMed ID: 25430682
    [TBL] [Abstract][Full Text] [Related]  

  • 28. miRNAs in acute myeloid leukemia.
    Liao Q; Wang B; Li X; Jiang G
    Oncotarget; 2017 Jan; 8(2):3666-3682. PubMed ID: 27705921
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNAs as novel biomarkers in diffuse large B-cell lymphoma--a systematic review.
    Jørgensen LK; Poulsen MØ; Laursen MB; Marques SC; Johnsen HE; Bøgsted M; Dybkær K
    Dan Med J; 2015 May; 62(5):. PubMed ID: 26050834
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The roles of microRNA in cancer and apoptosis.
    Lynam-Lennon N; Maher SG; Reynolds JV
    Biol Rev Camb Philos Soc; 2009 Feb; 84(1):55-71. PubMed ID: 19046400
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of mir-21, which is up-regulated during MYCN knockdown-mediated differentiation, does not prevent differentiation of neuroblastoma cells.
    Buechner J; Henriksen JR; Haug BH; Tømte E; Flaegstad T; Einvik C
    Differentiation; 2011 Jan; 81(1):25-34. PubMed ID: 20980091
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MicroRNA and Metastasis.
    Ma L
    Adv Cancer Res; 2016; 132():165-207. PubMed ID: 27613133
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNAs and multiple sclerosis: from physiopathology toward therapy.
    Zare-Shahabadi A; Renaudineau Y; Rezaei N
    Expert Opin Ther Targets; 2013 Dec; 17(12):1497-507. PubMed ID: 24053428
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNAs and cell differentiation in mammalian development.
    Song L; Tuan RS
    Birth Defects Res C Embryo Today; 2006 Jun; 78(2):140-9. PubMed ID: 16847891
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNAs and their emerging roles in immunology.
    Pauley KM; Chan EK
    Ann N Y Acad Sci; 2008 Nov; 1143():226-39. PubMed ID: 19076353
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Altered MicroRNA Expression Profiles in Activated Mast Cells Following IgE-FcεRI Cross-Linking with Antigen.
    Teng Y; Zhang R; Yu H; Wang H; Hong Z; Zhuang W; Huang Y
    Cell Physiol Biochem; 2015; 35(6):2098-110. PubMed ID: 25895812
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MiRNAs: potential diagnostic and therapeutic targets for cerebral ischaemia.
    Zhu R; Liu X; Zhu Y; He Z
    Neurol Res; 2016 Jan; 38(1):86-92. PubMed ID: 27078695
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Circulating microRNAs as diagnostic and prognostic tools for hepatocellular carcinoma.
    Zhang YC; Xu Z; Zhang TF; Wang YL
    World J Gastroenterol; 2015 Sep; 21(34):9853-62. PubMed ID: 26379392
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of microRNAs in B cell leukemias and lymphomas.
    Schmidt A; Küppers R
    Curr Mol Med; 2014; 14(5):580-97. PubMed ID: 24894178
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNAs in prostate cancer: From function to biomarker discovery.
    Moustafa AA; Kim H; Albeltagy RS; El-Habit OH; Abdel-Mageed AB
    Exp Biol Med (Maywood); 2018 Jun; 243(10):817-825. PubMed ID: 29932371
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.